Immunethep
PrivateLast Round
Grant
Apr 2, 2025
Total Funding Raised
$7.2M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Immunethep operates in Healthcare & Life Sciences and is based in Cantanhede. Its latest recorded funding round was a Grant round in April 2025.
Immunethep is a biotechnology company that develops preventive and therapeutic anti-bacterial immunotherapies targeting a shared virulence mechanism in pathogenic bacteria.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Immunethep Comparables
Compare Immunethep with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Vaxdyn | 87% | |
| Baxiva AG | 79% | |
| Eli Lilly and Company | 78% |
For institutional investors. Book with your work email.
Immunethep Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Apr 2, 2025 | ||||
| Grant | Feb 25, 2025 | ||||
| VC Round | Jul 31, 2024 | ||||
| Grant | Oct 18, 2022 | ||||
| Seed | Oct 18, 2018 | ||||
Grant | Oct 23, 2017 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Immunethep Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Innovation Council Fund | Grant |
| PACE (Pathways to Antimicrobial Clinical Efficacy) | Grant |
| CARB-X | Grant |
| Gates Foundation | Grant |
| Bill & Melinda Gates Foundation | Grant |
| Venture Catalysts | Pre Seed |
| Beta Capital | VC Round |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 1245% MoM, from 65 to 874.
- Jul 10, 2025
Monthly visitors grew 89% MoM, reaching 603.
For institutional investors. Book with your work email.
Immunethep Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Immunethep's valuation, stock price, and market status.
Is Immunethep a public or private company?
Immunethep is a private company.
What is the current stock price of Immunethep?
Immunethep is a private company, so its shares have no public market price. Caplight tracks Immunethep's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Immunethep worth (valuation)?
Valuation information for Immunethep is not publicly available.
Can I buy Immunethep stock?
Immunethep shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Immunethep's last funding round?
Immunethep's most recent funding round was Grant on April 2, 2025.
Who are the main investors in Immunethep?
Key investors in Immunethep include Beta Capital, Portugal Ventures.
Will Immunethep IPO soon?
No public IPO plans have been announced for Immunethep.
How can I track Immunethep secondary market activity?
Caplight tracks bids, offers, and trades in Immunethep's shares on secondary markets.